Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 65

1.

Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial.

Onken JE, Bregman DB, Harrington RA, Morris D, Buerkert J, Hamerski D, Iftikhar H, Mangoo-Karim R, Martin ER, Martinez CO, Newman GE, Qunibi WY, Ross DL, Singh B, Smith MT, Butcher A, Koch TA, Goodnough LT.

Nephrol Dial Transplant. 2014 Apr;29(4):833-42. doi: 10.1093/ndt/gft251. Epub 2013 Aug 20.

PMID:
23963731
[PubMed - in process]
2.

Severe hypernatremia following treatment of the syndrome of inappropriate antidiuretic hormone secretion.

Soudan K, Qunibi W.

Am J Med Sci. 2012 Jun;343(6):507-9. doi: 10.1097/MAJ.0b013e318245faaf.

PMID:
22270390
[PubMed - indexed for MEDLINE]
3.

A randomized, double-blind, placebo-controlled trial of calcium acetate on serum phosphorus concentrations in patients with advanced non-dialysis-dependent chronic kidney disease.

Qunibi W, Winkelmayer WC, Solomon R, Moustafa M, Kessler P, Ho CH, Greenberg J, Diaz-Buxo JA.

BMC Nephrol. 2011 Feb 16;12:9. doi: 10.1186/1471-2369-12-9.

PMID:
21324193
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Target levels for serum phosphorus and parathyroid hormone.

Qunibi W, Kalantar-Zadeh K.

Semin Dial. 2011 Jan-Feb;24(1):29-33. doi: 10.1111/j.1525-139X.2010.00823.x. Epub 2011 Feb 17. Review. No abstract available.

PMID:
21324001
[PubMed - indexed for MEDLINE]
5.

A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients.

Qunibi WY, Martinez C, Smith M, Benjamin J, Mangione A, Roger SD.

Nephrol Dial Transplant. 2011 May;26(5):1599-607. doi: 10.1093/ndt/gfq613. Epub 2010 Oct 7.

PMID:
20929915
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

The efficacy and safety of current intravenous iron preparations for the management of iron-deficiency anaemia: a review.

Qunibi WY.

Arzneimittelforschung. 2010;60(6a):399-412. doi: 10.1055/s-0031-1296304. Review.

PMID:
20648931
[PubMed - indexed for MEDLINE]
7.

Treatment of vitamin D deficiency in CKD patients with ergocalciferol: are current K/DOQI treatment guidelines adequate?

Qunibi WY, Abdellatif A, Sankar S, Hamdan Z, Lin FY, Ingle J, Cadena A, Gelfond J, Kasinath B.

Clin Nephrol. 2010 Apr;73(4):276-85.

PMID:
20353735
[PubMed - indexed for MEDLINE]
8.

Progression of calcification in the Calcium Acetate Renagel Evaluation-2 (CARE-2) Study.

Qunibi W, Muenz LR.

Am J Kidney Dis. 2008 Nov;52(5):1022-3; author reply 1023-4. doi: 10.1053/j.ajkd.2008.07.043. No abstract available.

PMID:
18971017
[PubMed - indexed for MEDLINE]
9.

The CARE-2 study results: setting the record straight.

Qunibi W, Muenz LR, Diaz-Buxo JA.

Nephrol Dial Transplant. 2008 Dec;23(12):4081-2; author reply 4082-3. doi: 10.1093/ndt/gfn520. Epub 2008 Sep 26. No abstract available.

PMID:
18820282
[PubMed - indexed for MEDLINE]
Free Article
10.

A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study.

Qunibi W, Moustafa M, Muenz LR, He DY, Kessler PD, Diaz-Buxo JA, Budoff M; CARE-2 Investigators.

Am J Kidney Dis. 2008 Jun;51(6):952-65. doi: 10.1053/j.ajkd.2008.02.298. Epub 2008 Apr 18.

PMID:
18423809
[PubMed - indexed for MEDLINE]
11.

The interscan variation of CT coronary artery calcification score: analysis of the Calcium Acetate Renagel Comparison (CARE)-2 study.

Budoff MJ, Kessler P, Gao YL, Qunibi W, Moustafa M, Mao SS.

Acad Radiol. 2008 Jan;15(1):58-61.

PMID:
18078907
[PubMed - indexed for MEDLINE]
12.

Cardiovascular calcification in nondialyzed patients with chronic kidney disease.

Qunibi WY.

Semin Dial. 2007 Mar-Apr;20(2):134-8. Review.

PMID:
17374087
[PubMed - indexed for MEDLINE]
13.

Does sevelamer have anti-atherosclerotic properties in maintenance hemodialysis patients?

Qunibi WY.

Nat Clin Pract Nephrol. 2005 Nov;1(1):18-9. No abstract available.

PMID:
16932359
[PubMed]
14.

The CARE study and cardiovascular calcification.

Qunibi WY.

Manag Care. 2006 Mar;15(3 Suppl):1-5.

PMID:
16604943
[PubMed - indexed for MEDLINE]
Free Article
15.

Effects of sevelamer and calcium on coronary artery calcification in patients new to dialysis: time for better controlled clinical trials.

Qunibi WY.

Kidney Int. 2006 Mar;69(6):1093. No abstract available.

PMID:
16528261
[PubMed - indexed for MEDLINE]
16.

Reducing the burden of cardiovascular calcification in patients with chronic kidney disease.

Qunibi WY.

J Am Soc Nephrol. 2005 Nov;16 Suppl 2:S95-102. Review.

PMID:
16251249
[PubMed - indexed for MEDLINE]
Free Article
17.

Cardiovascular calcification in Hispanic Americans (HA) with chronic kidney disease (CKD) due to type 2 diabetes.

Qunibi WY, Abouzahr F, Mizani MR, Nolan CR, Arya R, Hunt KJ.

Kidney Int. 2005 Jul;68(1):271-7.

PMID:
15954917
[PubMed - indexed for MEDLINE]
18.

Dyslipidemia and progression of cardiovascular calcification (CVC) in patients with end-stage renal disease (ESRD).

Qunibi WY.

Kidney Int Suppl. 2005 Jun;(95):S43-50. Review.

PMID:
15882313
[PubMed - indexed for MEDLINE]
Free Article
19.

Treatment of hyperphosphatemia in patients with chronic kidney disease on maintenance hemodialysis.

Nolan CR, Qunibi WY.

Kidney Int Suppl. 2005 Jun;(95):S13-20. Review.

PMID:
15882308
[PubMed - indexed for MEDLINE]
Free Article
20.

Comparison of intravenous iron sucrose to oral iron in the treatment of anemic patients with chronic kidney disease not on dialysis.

Charytan C, Qunibi W, Bailie GR; Venofer Clinical Studies Group.

Nephron Clin Pract. 2005;100(3):c55-62. Epub 2005 Apr 11.

PMID:
15824508
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk